Novartis (NVS) has agreed to acquire Regulus Therapeutics (RGLS) for an initial payment of $7.00 per share in cash at closing, or $800 million, Regulus said Wednesday.
Shares of Regulus more than doubled as intraday trading volume soared to over 23.4 million from a daily average of about 1.3 million.
Oddity Tech (ODD) reported Q1 adjusted earnings and sales late Tuesday above forecasts and raised its full-year EPS and revenue guidance.
Shares soared 26% as intraday trading volume surged to more than 4.2 million from a daily average of about 458,000.
Jeffs' Brands (JFBR) said Wednesday that it signed a definitive agreement to sell its Smart Repair Pro unit and its 49.1% stake in SciSparc Nutraceuticals to Plantify Foods.
Shares jumped 52% as intraday trading volume catapulted to over 85.8 million compared with a daily average of about 317,000.
Price: 113.49, Change: +0.04, Percent Change: +0.04
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.